Nalfon 200 Side Effects
Generic Name: fenoprofen, fenoprofen calcium
Please note - some side effects for Nalfon 200 may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
Side Effects by Body System - for Healthcare Professionals
Applies to: compounding powder; oral capsule; oral tablet
Gastrointestinal
Patients with a history of serious gastrointestinal events or alcohol abuse are at increased risk for severe gastrointestinal side effects. Fenoprofen should be used with caution in these patients.
Gastrointestinal side effects have been reported frequently. These have included dyspepsia (up to 10%), nausea, vomiting, abdominal pain, and constipation. More serious gastrointestinal side effects include peptic ulcer with or without perforation, gastrointestinal hemorrhage, and pancreatitis.
Hepatic
Hepatic side effects have included elevations in liver function tests, which may occur in up to 15% of patients. In addition, jaundice and cholestatic hepatitis have been reported.
Elevations in liver function tests to three times normal values occur in less than 1% of patients.
Cautious use of fenoprofen with frequent monitoring of the liver function tests is recommended in patients with liver disease,
Renal
Renal side effects have included increased serum creatinine and blood urea nitrogen, oliguria, hematuria, cystitis, interstitial nephritis, nephrotic syndrome, and renal papillary necrosis.
Idiosyncratic nephropathy is seen more frequently with fenoprofen than with other nonsteroidal anti-inflammatory agents, and may occur days to months after initiation of therapy.
Fenoprofen may impair the ability of the kidney to cope with low renal blood flow states due to inhibition of prostaglandin-dependent afferent arteriolar vasodilation. Renal function may be further compromised in patients with heart failure, hypovolemia, cirrhosis, nephrotic syndrome, or hypoalbuminemia. Additional risk factors for nonsteroidal anti-inflammatory drug-induced renal insufficiency are advanced age and concomitant use of diuretics.
A case-control study suggested that patients who consumed 5000 or more pills containing NSAIDs during their lifetime may be at increased risk for end-stage renal disease.
Patients with reduced renal function may be at increased risk for renal side effects.
Hypersensitivity
Hypersensitivity side effects have been reported rarely. These have included eosinophilia. rash, angioedema, bronchospasm, and anaphylaxis. Fenoprofen-associated nephritis may be due to a hypersensitivity. In addition, rare cases of pulmonary hypersensitivity and severe dermatologic reactions have been reported.
Hematologic
Hematological side effects have included platelet dysfunction, thrombocytopenia, agranulocytosis, pure red cell aplasia, hemolytic anemia, and aplastic anemia.
Nervous system
Nervous system side effects have been rare. These have included dizziness, headache, nervousness, asthenia, and fatigue.
Dermatologic
Dermatologic side effects have included increased sweating, pruritus, and rash. In addition, rare cases of exfoliative dermatitis, Stevens-Johnson syndrome, and toxic epidermal necrolysis have been reported.
Other
Lab values which may be altered by fenoprofen include elevated free and total triiodothyronine (T3) due to interference with the T3 assay.
Cardiovascular
Nonsteroidal anti-inflammatory drugs (NSAIDs) may elevate blood pressure and antagonize the blood-pressure lowering effect of antihypertensive mediations in patients already being treated with antihypertensive drugs.
Cardiovascular side effects have included edema and palpitations. In addition, blood pressure may be elevated by fenoprofen, which may have clinical relevance in patients with comorbid illnesses.
Top- fenoprofen MedFacts Consumer Leaflet (Wolters Kluwer)
- fenoprofen Advanced Consumer (Micromedex) - Includes Dosage Information
- Fenoprofen Prescribing Information (FDA)
- fenoprofen Concise Consumer Information (Cerner Multum)
- Fenoprofen Calcium Monograph (AHFS DI)
- Nalfon Prescribing Information (FDA)
- Nalfon MedFacts Consumer Leaflet (Wolters Kluwer)
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.


